FDA guidances round out 'modernized' trial design framework

In line with outgoing FDA Commissioner Scott Gottlieb's push to modernize drug, biologic and device development, FDA released additional guidances Thursday to help sponsors design trials more efficiently, including a framework on targeted drug and biologic development. Gottlieb previewed the guidances in

Read the full 423 word article

User Sign In